Moderate riskFDA DrugClass III

Slate Run Pharmaceuticals Eptifibatide Injection recalled for incorrect dosing instruction labeling

Slate Run Pharmaceuticals is recalling Eptifibatide Injection 75 mg/100 mL vials because the carton label says "weight-adjusted bolus dosing" when it should say "weight-adjusted infusion." This labeling error could lead to incorrect administration of the medication. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. If you are a healthcare provider or facility using this medication, verify the correct dosing method is weight-adjusted infusion, not bolus dosing.
  2. Contact Slate Run Pharmaceuticals or your pharmacy if you have questions about proper administration.
  3. Do not use this medication until you confirm the correct dosing instructions with your healthcare provider or pharmacist.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx Only, Manufactured by: Hainan Poly Pharm. Co., Ltd., Guilinyang Economic Development Area, Haikou, Hainan Province, China 571127; Distributed by: Slate Run Pharmaceuticals, LLC, Columbus, Ohio 43215. NDC Slate Run Carton Label: 70436-027-80; NDC ProRx Carton Label: 70436-163-80
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
277 W Nationwide Blvd Ste 260, N/A, Columbus, OH, United States
Classification
Class III
Recall number
D-0343-2026

In the FDA's words

Description
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx Only, Manufactured by: Hainan Poly Pharm. Co., Ltd., Guilinyang Economic Development Area, Haikou, Hainan Province, China 571127; Distributed by: Slate Run Pharmaceuticals, LLC, Columbus, Ohio 43215. NDC Slate Run Carton Label: 70436-027-80; NDC ProRx Carton Label: 70436-163-80 Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion. All lots within expiry Distribution: Nationwide within the USA. Affected quantity: N/A
Hazard
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

Related topics

Label mix upDrugsSold nationwideMore from FDA Drug